首页> 外文期刊>Mutation Research: International Journal on Mutagenesis, Chromosome Breakage and Related Subjects >Biomarkers in molecular epidemiology studies for health risk prediction.
【24h】

Biomarkers in molecular epidemiology studies for health risk prediction.

机译:分子流行病学研究中的生物标志物,可预测健康风险。

获取原文
获取原文并翻译 | 示例
           

摘要

The field of molecular epidemiology is very promising, as sophisticated techniques are being developed to address etiology, genetic susceptibility and mechanisms for induction of disease. The use of biomarkers plays a key role in these investigations because the information can be used to predict the development of disease and to implement disease prevention programs. However, as emphasized by Frederica P. Perera, the field is strewn with studies either that failed to use validated biomarkers or whose designs did not adequately consider the biology of the endpoints, and the availability of validated biomarkers of health risk is still limited. In this review, we have briefly described the usefulness of certain biomarkers for the documentation of exposure and early biological effects, with special concern for the prediction of cancer. An emphasis is placed on understanding the biological and health significance of biomarkers. By building reliable biomarker databases, a promising future is the integration of information from the genome programs to expand the scientific frontiers on etiology, health risk prediction and prevention of environmental disease.
机译:分子流行病学领域非常有前景,因为正在开发复杂的技术来解决病因,遗传易感性和诱发疾病的机制。生物标记物的使用在这些研究中起着关键作用,因为该信息可用于预测疾病的发展和实施疾病预防计划。但是,正如Frederica P. Perera所强调的那样,该领域的研究要么没有使用经过验证的生物标记,要么其设计没有充分考虑终点的生物学特性,因此经过验证的健康风险生物标记的可用性仍然有限。在这篇综述中,我们简要描述了某些生物标记物对暴露和早期生物学效应的记录的有用性,特别关注癌症的预测。重点放在了解生物标志物的生物学和健康意义上。通过建立可靠的生物标志物数据库,一个有前途的未来是整合来自基因组计划的信息,以扩大病因学,健康风险预测和环境疾病预防的科学前沿。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号